Microemulsion based Hydrogel of Mycophenolate Mofetil for the Treatment of Psoriasis

Order of Publishing in Issue: 
Volume :8
Issue :4
October, 2014
Page No: 
Kusha Sharma and Neena Bedi[*]
Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar-143005, India

Mycophenolate mofetil (MMF), the morpholinoethyl ester of mycophenolic acid is an immunosuppressive agent used to prevent organ rejection after kidney and heart transplant. The drug seem to be effective in dermal diseases mainly psoriasis. However, till date it can be only be administered using systemic route which is often associated with side effects such as nausea, leucopenia, sepsis and diarrheoa. The aim of the present study was to develop microemulsion based hydrogel for topical delivery of mycophenolate mofetil and to investigate its in vitro release and its potential in treating psoriatic inflammation using imiquimod induced skin inflammation animal model. Pseudoternary phase diagrams were constructed and on the basis of microemulsion existence range, various formulations were developed using oleic acid, Tween80, propylene glycol and distilled water as oil phase, surfactant, cosurfactant and aqueous phase, respectively. The selected formulations were subjected to physical stability studies and consequently to various physicochemical characterization. The optimized formulation (F2) consisting of 6.06% v/v of oleic acid 36.36% v/v of Tween80 and 18.18% v/v of propylene glycol has shown a globule size of 124 nm, refractive index 1.421, zeta potential -34.35 ±0.051 mV, pH 5.9 and conductivity value of 104 μS cm-1. The permeability of drug from microemulsion after 24 h was observed to be 69.52%. Carbopol 940 was used to convert microemulsion into microemulsion based hydrogel to improve its viscosity for topical administration and was characterized. The histopathological studies performed on mice skin revealed that the treated skin showed complete clearance of hyperkeratotic plaques and a significant reduction in the area of perakeratosis. The results indicated that the formulated gel may be a promising vehicle for topical delivery of mycophenolate mofetil for the treatment of psoriasis.

Microemulsion, mycophenolate mofetil, psoriasis, topical drug delivery
PDF 3.29 MB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



Upcoming 0 events

  • No upcoming events available

User login